Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | CCKBR | P32239 | 13/20 | 0.36 |
| ▸ | PTH1R | Q03431 | 4/20 | 0.35 |
| ▸ | PTPRC | P08575 | 1/20 | 0.34 |
| ▸ | PTPRF | P10586 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | CDC25B | P30305 | 1/20 | 0.34 |
| ▸ | CCKAR | P32238 | 2/20 | 0.33 |
| ▸ | OXTR | P30559 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28295463 | 0.75 | GABRA1 (0.43) | CHRM1CCKBR | |
| SCHEMBL9008757 | 0.65 | ALDH1A1 (0.42) | CCKBRPTH1RCCKAROXTR | |
| SCHEMBL9008759 | 0.65 | ALDH1A1 (0.42) | CCKBRPTH1RCCKAROXTR | |
| SCHEMBL9008752 | 0.65 | ALDH1A1 (0.42) | CCKBRPTH1RCCKAROXTR | |
| SCHEMBL4414712 | 0.65 | GABRP (0.56) | CCKBRCCKAR | |
| SCHEMBL7682526 | 0.65 | GABRP (0.56) | CCKBRCCKAR | |
| SCHEMBL8824651 | 0.65 | GABRP (0.56) | CCKBRCCKAR | |
| SCHEMBL9383632 | 0.65 | CCKBR (0.37) | CCKBRPTH1R | |
| SCHEMBL8824718 | 0.65 | GABRP (0.56) | CCKBRCCKAR | |
| SCHEMBL9383622 | 0.65 | CCKBR (0.37) | CCKBRPTH1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109906220-A | For treating the 1,3- dihydro -1,4- benzodiazepine * -2- thione compounds of CNS related disease | 豪夫迈·罗氏有限公司 | 2019-06-18 | — | — | CN | claimed |
| CN-109906220-A | For treating the 1,3- dihydro -1,4- benzodiazepine * -2- thione compounds of CNS related disease | 豪夫迈·罗氏有限公司 | 2019-06-18 | — | — | CN | disclosed |